Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rs11614913 in pri-
miR-196a-2
is involved in the occurrence of many diseases, especially in cancers. However, it remains unknown whether
miR-196a-2
is associated with human recurrent spontaneous abortion (RSA) in Chinese Han population. Our study found that rs11614913 T/T in pri-
miR-196a-2
was associated with the increase risk of human unexplained RSA (URSA) in recessive mode in Chinese Han population. The T allele of rs11614913 increased the production of mature
miR-196a-3p
. Rs11614913 T/T inhibited
HTR
-8/SVneo cells proliferation and migration and promoted cells apoptosis. Further investigation discovered that
dihydrofolate reductase
(
DHFR
) was the target of
miR-196a-3p
and inversely regulated by
miR-196a-3p
. Dual-luciferase assay indicated that T allele in
miR-196a-2
rs11614913 could more effectively suppress
DHFR
expression than C allele. In addition, C to T substitution in
miR-196a-2
rs11614913 attenuated the sensibility of cells to mifepristone. Collectively, our data suggest that
miR-196a-2
rs11614913 T/T in pri-
miR-196a-2
may be conductive to the genetic predisposition to RSA by disrupting the production of mature
miR-196a-3p
and reinforcing the expression of
DHFR
.
...
PMID:The polymorphism of rs11614913 T/T in pri-
miR-196a-2
alters the miRNA expression and associates with recurrent spontaneous abortion in a Han-Chinese population. 3250 88